These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6500809)

  • 21. [Effect of gender and body mass on hemodialysis dose].
    Kovacić V; Sain M; Dzanko D
    Acta Med Croatica; 2003; 57(1):33-7. PubMed ID: 12876860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of hemodiafiltration in the treatment of patients with uremia].
    Burtsev VI; Troĭniakov NK; Rashupkina ZP; Burlinova LP; Karavaeva MG; Kalashnikov SV; Minchenkov AV; Ptitsina SV; Vasina TI
    Klin Med (Mosk); 1995; 73(4):73-5. PubMed ID: 7474828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH; Butt WW
    ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soft and hard hemodiafiltration (HDF).
    Cioni L; Pilone N; Rindi P
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():5-8. PubMed ID: 3557672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
    Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The basic, quantifiable parameter of dialysis prescription is Kt/V urea; treatment time is determined by the ultrafiltration requirement; all three parameters are of equal importance.
    Gotch F
    Blood Purif; 2007; 25(1):18-26. PubMed ID: 17170532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodiafiltration.
    Sprenger KB
    Life Support Syst; 1983; 1(2):127-36. PubMed ID: 6679009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
    Mandolfo S; Borlandelli S; Imbasciati E; Badalamenti S; Graziani G; Sereni L; Varesani M; Wratten ML; Corsi A; Elli A
    Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automatic continuous venovenous hemodiafiltration in cardiosurgical patients.
    Caprioli R; Favilla G; Palmarini D; Comite C; Gemignani R; Rindi P; Cioni L
    ASAIO J; 1993; 39(3):M606-8. PubMed ID: 8268609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
    Krieter DH; Hunn E; Morgenroth A; Lemke HD; Wanner C
    Artif Organs; 2008 Dec; 32(12):903-9. PubMed ID: 19133017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of lead poisoning by drinking water using hemofiltration and chelationin a hemodialysed anuric patient].
    Kessler M; Durand PY; Kaminski E; Louis J; Cao Huu T; Royer-Moreau MJ; Duc M
    Nephrologie; 1985; 6(5):235-8. PubMed ID: 3937966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodiafiltration using readily available equipment.
    Kohnle W; Sprenger K; Spohn B; Franz HE
    J Dial; 1979; 3(1):27-39. PubMed ID: 381340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fallacies of high-speed hemodialysis.
    Twardowski ZJ
    Hemodial Int; 2003 Apr; 7(2):109-17. PubMed ID: 19379349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspects of the on-line hemodiafiltration with regeneration and reinfusion of the ultrafiltrate (HFR): multicenter study].
    De Simone W; De Simone M; De Simone A; Iannaccone S; Manganelli R; Zito B; Guastaferro P; Apperti V; Paglionico C; Salvati G; Veniero P; Ferro F; Tedesco V
    G Ital Nefrol; 2004; 21 Suppl 30():S161-7. PubMed ID: 15750977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No difference in nitrogen balance between standard prescriptions of hemodialysis and peritoneal dialysis.
    Lu Q; Cheng L; Axelsson J; Lindholm B; Wang T
    Blood Purif; 2008; 26(6):511-7. PubMed ID: 18931478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrashort hemodiafiltration: efficiency and hemodynamic tolerance.
    Wizemann V; Kramer W; Knopp G; Rawer P; Mueller K; Schütterle G
    Clin Nephrol; 1983 Jan; 19(1):24-30. PubMed ID: 6831775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
    Kaplan SL; Berry PL; Mason EO; Kramer WG
    Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of high-efficiency hemodialysis treatments: long-term assessment.
    Bosch JP; Lew SQ; Barlee V; Mishkin GJ; von Albertini B
    Hemodial Int; 2006 Jan; 10(1):73-81. PubMed ID: 16441831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Search for optimizing dialysis therapy. I. Acute effects of hemodiafiltration with a highly permeable membrane and a large dose of convection and diffusion.
    Wizemann V; Birk HW; Vanholder R; de Smet R; Ringoir S; Bleyl H; Schütterle G
    Blood Purif; 1988; 6(3):145-55. PubMed ID: 3395474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.